Leu-AMS is a potent inhibitor of leucyl-tRNA synthetase (LRS) with an IC50 value of 22.34 nM; it inhibits the catalytic activity of LRS without affecting leucine-induced mTORC1 activation; it exhibits cytotoxicity in both cancer and normal cells; it inhibits bacterial growth.